Upstream Medical Technologies is a leading brand focused on transforming cardiovascular healthcare. They are dedicated to developing novel biomarkers through clinical studies that rapidly identify patients with cardiac ischemia, an important precursor to heart attacks. Their aim is to reduce morbidity and mortality, as well as the burden on overloaded healthcare systems.

By providing physicians with rapid and accurate diagnostic tools, Upstream empowers them to prioritize resources on those most at risk. One of their breakthrough products is Marker C, a patented diagnostic blood test. Marker C allows for the diagnosis of patients at risk of having a heart attack within hours of presentation to an emergency room.

With a proven team of experts and a commitment to innovation, Upstream Medical Technologies is revolutionizing cardiovascular healthcare. Stay updated with their latest research, insights, and announcements by connecting with them on LinkedIn